Skip to main content
. 2021 Jun 8;9:691585. doi: 10.3389/fcell.2021.691585

TABLE 1.

Animal models of pulmonary hypertension.

Cause Histological features Animal models
Group 1: Pulmonary arterial hypertension (PAH)
Idiopathic PAH Pulmonary artery intimal proliferation Su-Hx rat/mouse
Heritable PAH Pulmonary artery medical hypertrophy MCT rat
Drugs/Toxin/Others Plexiform lesions Su-Hx-Normoxia
Group 2: Pulmonary hypertension with left heart disease
Left-sided heart disease Pulmonary medical hypertrophy SU5416/Obese ZSF1 rat
Pulmonary vein arterialization
Pulmonary interstitial edema
Group 3: Pulmonary hypertension associated with lung disease
and/or hypoxemia
High altitudes Hypoxic pulmonary vasoconstriction Su-Hx rat/mouse
COPD/Pulmonary fibrosis Muscularization of arterioles Hypoxia rat/mouse
Obstructive sleep apnea
Group 4: Pulmonary hypertension due to chronic thrombotic and/or
embolic disease
Pulmonary emboli Thrombi or embolism Vena cava ligation
Other clotting disorders Recanalized organized thrombi
Group 5: Pulmonary hypertension triggered by other health conditions
Heterogeneous Heterogeneous